Abstract
The Intrauterine Device (IUD) is the most commonly used form of reversible contraception throughout the world [1], and in some countries it accounts for 40% of the contraception used by women [2]. In the United States (US), current use is 0.8% of the contraceptive population [3]. Prior to issues with infection and infertility with the Dalkon Shield in the 1970s, use in the US approached 10%. The newer IUDs are safe and effective forms of birth control when used in appropriate patients. Not only effective in preventing pregnancy with a failure rate of 0.42%, but if used for at least 5 years, it is one of the least expensive forms of birth control [4]. There are two IUDs currently in use in the US, the copper T 380A (in place for up to 10 years) and the levonorgestrel intrauterine system (in place for up to 5 years).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anonymous. IUDs: an update. Popul Rep B 1995;6:1–35.
Mauldin WP, Segal SJ. IUD use throughout the world: past, present and future. In Bardin CW, Mishell DR Jr (eds) Proceedings from the Fourth International Conference on IUDs. Boston, MA: Butterworth-Heinemann, 1994, pp 1–10.
Piccinino LJ, Mosher WD. Trends in contraceptive use in the United States: 1982–1995. Fam Plann Perspect 1998;30:4–10, 46.
Trussell J, Leveque JA, Koenig JD, London R, Borden S, Henneberry J, LaGuardia KD, Stewart F, Wilson TG, Wysocki S. The economic value of contraception: a comparison of 15 methods. Am J Public Health 1995;85(4):494–503.
Canavan TP. Appropriate use of the intrauterine device. Am Fam Physician 1998;58(9):2077–2084, 2087–2088.
Xiong X, Buekens P, Wollast E. IUD use and the risk of ectopic pregnancy: a meta-analysis of case-control studies. Contraception 1995;52:23–34.
World Health Organization. Medical eligibility criteria for contraceptive use, 3rd edn. Geneva: WHO, 2004.
ACOG Practice Bulletin, Intrauterine Device, Number 59, January 2005.
Paragard package insert, FEI Products LLC, last revision September 2005.
White MK, Ory HW, Rooks JB, Rochat RW. Intrauterine device termination rates and the menstrual cycle day of insertion. Obstet Gynecol 1980;55:220–224.
Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992;339:785–788.
Grimes DA, Schulz FK. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev 1999, Issue 3. Art. No.: CD001327. DOI: 10.1002/14651858.CD001327.
Johnson BA. Insertion and removal of intrauterine devices. Am Fam Physician 2005;71(1): 95–102.
Additional Resources Website
Supplier: Duramed Pharmaceuticals: www.paragard.com
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
McNany, E.H. (2010). Copper Intrauterine Device. In: Sulik, S., Heath, C. (eds) Primary Care Procedures in Women's Health. Springer, New York, NY. https://doi.org/10.1007/978-0-387-76604-1_11
Download citation
DOI: https://doi.org/10.1007/978-0-387-76604-1_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-76598-3
Online ISBN: 978-0-387-76604-1
eBook Packages: MedicineMedicine (R0)